The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.

In Q1 2024, Abbott's FreeStyle Libre sales grew 25.5% to reach $1.5bn. The Plus version is gradually replacing the older FreeStyle Libre 2 sensor across many markets.

Abbott Launches Next-Gen FreeStyle Libre® 2 Plus with Continuous Glucose Readings Every Minute & Optional Alarms ...

Abbott's world-leading 1 FreeStyle Libre 2 and 3 systems for people living with diabetes are now the only continuous glucose monitoring sensors 2 in the U.S. that users do not need to remove during ...

Pharma giant Abbott said today it had received approval from the FDA for its next-generation glucose monitoring system for ages four and older with diabetes. The FreeStyle Libre 2 iCGM has a 14 ...

Real-world data showed the use of a continuous glucose monitoring system was able to substantially reduce A1c levels among people with Type 2 diabetes regardless of whether they were taki | Real ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to ...

Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.

Abbott Laboratories ABT recently announced that the FreeStyle Libre 2 system's reimbursement coverage has been expanded by the French health authority to cover individuals using basal insulin as ...

Abbott has launched the FreeStyle Libre 2 Plus in India, a state-of-the-art continuous glucose monitoring system providing real-time readings and alerts for diabetics. This innovative device aims to ...

4.2M FreeStyle Libre glucose monitors recalled by FDA for risk of overheating, fire The issue affects more than 4.2 million devices across the US, the FDA says.

Also called flash or intermittently scanned glucose monitoring, the Libre helps reduce hypoglycemia and improves some aspects of quality of life, but it doesn't consistently reduce A1c.